224 related articles for article (PubMed ID: 21097744)
61. [Immune reconstitution syndrome due to BCG in HIV-treated children].
Miranda-Choque E; Candela-Herrera J; R Segura E; Farfán-Ramos S; Barriga A
Rev Peru Med Exp Salud Publica; 2012; 29(4):498-502. PubMed ID: 23338635
[TBL] [Abstract][Full Text] [Related]
62. Disseminated infection with Bacillus Calmette-Guerin in a child with advanced HIV disease.
Rosenfeldt V; Paerregaard A; Valerius NH
Scand J Infect Dis; 1997; 29(5):526-7. PubMed ID: 9435049
[TBL] [Abstract][Full Text] [Related]
63. Fulminant BCG Disease in a 7 Month Old Healthy Male Infant.
Sharma S; Tanigasalam V; Parameswaran N; Chandrasekaran V; Gulati R; Joseph NM; Chandrashekar L
J Trop Pediatr; 2015 Dec; 61(6):474-7. PubMed ID: 26423512
[TBL] [Abstract][Full Text] [Related]
64. Disseminated bacille Calmette-Guérin disease after vaccination: case report and review.
Talbot EA; Perkins MD; Silva SF; Frothingham R
Clin Infect Dis; 1997 Jun; 24(6):1139-46. PubMed ID: 9195072
[TBL] [Abstract][Full Text] [Related]
65. Multiplex PCR-identified cutaneous tuberculosis evoked by Mycobacterium bovis BCG vaccination in a healthy baby.
Okazaki T; Ebihara S; Takahashi H; Asada M; Sato A; Seki M; Ohto H; Sasaki H
J Clin Microbiol; 2005 Jan; 43(1):523-5. PubMed ID: 15635035
[TBL] [Abstract][Full Text] [Related]
66. [Bacille Calmette-Guérin adenitis: diagnostic and therapeutic guidelines].
Constant C; Figueiredo A; Brito MJ
Acta Med Port; 2011 Dec; 24 Suppl 2():263-8. PubMed ID: 22849911
[TBL] [Abstract][Full Text] [Related]
67. Bacillus Calmette-Guerin lymphadenitis: a 6-year experience in two Saudi hospitals.
Bukhari E; Alzahrani M; Alsubaie S; Alrabiaah A; Alzamil F
Indian J Pathol Microbiol; 2012; 55(2):202-5. PubMed ID: 22771644
[TBL] [Abstract][Full Text] [Related]
68. Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants.
Hesseling AC; Johnson LF; Jaspan H; Cotton MF; Whitelaw A; Schaaf HS; Fine PE; Eley BS; Marais BJ; Nuttall J; Beyers N; Godfrey-Faussett P
Bull World Health Organ; 2009 Jul; 87(7):505-11. PubMed ID: 19649364
[TBL] [Abstract][Full Text] [Related]
69. Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children.
Van-Dunem JC; Rodrigues LC; Alencar LC; Militão-Albuquerque Mde F; Ximenes RA
Biomed Res Int; 2015; 2015():275029. PubMed ID: 26221585
[TBL] [Abstract][Full Text] [Related]
70. Reduced rate of adverse reactions to the BCG vaccine in children exposed to the vertical transmission of HIV infection and in HIV-infected children from an endemic setting in Brazil.
Fernandes RC; de Araújo LC; Medina-Acosta E
Eur J Pediatr; 2009 Jun; 168(6):691-6. PubMed ID: 18766374
[TBL] [Abstract][Full Text] [Related]
71. Papulonecrotic tuberculid after Bacillus Calmette-Guérin (BCG) vaccination with lung infiltration that mimics disseminated BCG infection.
Miyamura T; Egashira S; Yoshino Y; Sawatari M; Nishihara T; Ihn H
J Dermatol; 2019 Aug; 46(8):e267-e268. PubMed ID: 30811058
[No Abstract] [Full Text] [Related]
72. Clinical, Microbiological Profile and Treatment Outcomes of Infants with BCG Adenitis: A Retrospective Study.
Dash N; Verghese VP; Rose W; Michael JS; Rebekah G; Venkatesan M; Chacko A
J Trop Pediatr; 2022 Oct; 68(6):. PubMed ID: 36370459
[TBL] [Abstract][Full Text] [Related]
73. Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine.
Alrabiaah AA; Alsubaie SS; Bukhari EI; Gad A; Alzamel FA
Ann Saudi Med; 2012; 32(1):4-8. PubMed ID: 22156633
[TBL] [Abstract][Full Text] [Related]
74. Disseminated Bacille Calmette-Guérin infection in a patient with severe combined immunodeficiency caused by JAK3 gene mutation.
Li M; Chen Z; Zhu Y; Chen J
Pediatr Dermatol; 2019 Sep; 36(5):672-676. PubMed ID: 31309596
[TBL] [Abstract][Full Text] [Related]
75. Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette-Guérin (BCG) among HIV- positive children and adults in Zambia.
Waddell RD; Lishimpi K; von Reyn CF; Chintu C; Baboo KS; Kreiswirth B; Talbot EA; Karagas MR;
AIDS; 2001 Jan; 15(1):55-60. PubMed ID: 11192868
[TBL] [Abstract][Full Text] [Related]
76. Complications of bacille Calmette-Guérin (BCG) vaccination and immunotherapy and their management.
Grange JM
Commun Dis Public Health; 1998 Jun; 1(2):84-8. PubMed ID: 9644119
[TBL] [Abstract][Full Text] [Related]
77. Disseminated BCG as a unique feature of an infant with severe combined immunodeficiency.
Norouzi S; Movahedi Z; Mamishi S; Monajemzadeh M; Rezaei N
Turk J Pediatr; 2011; 53(3):328-32. PubMed ID: 21980818
[TBL] [Abstract][Full Text] [Related]
78. Mycobacterium bovis (BCG) vaccination. Progressive disease in a patient asymptomatically infected with the human immunodeficiency virus.
Lumb R; Shaw D
Med J Aust; 1992 Feb; 156(4):286-7. PubMed ID: 1738331
[TBL] [Abstract][Full Text] [Related]
79. Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations.
Lee PP
Ann Acad Med Singap; 2015 Aug; 44(8):297-301. PubMed ID: 26477962
[TBL] [Abstract][Full Text] [Related]
80. Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature.
Antaya RJ; Gardner ES; Bettencourt MS; Daines M; Denise Y; Uthaisangsook S; Buckley RH; Prose NS
Pediatr Dermatol; 2001; 18(3):205-9. PubMed ID: 11437999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
